(Q41696774)

7 October 2017

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance (English)

1 reference

7 October 2017

United States of America

0 references

1 reference

1 reference

10

Pfaller MA

1 reference

7 October 2017

Kao AS

1

1 reference

7 October 2017

Brandt ME

2

1 reference

7 October 2017

Pruitt WR

3

1 reference

7 October 2017

Conn LA

4

1 reference

7 October 2017

Perkins BA

5

1 reference

7 October 2017

Stephens DS

6

1 reference

7 October 2017

Baughman WS

7

1 reference

7 October 2017

Reingold AL

8

1 reference

7 October 2017

Rothrock GA

9

1 reference

7 October 2017

Pinner RW

11

1 reference

7 October 2017

Hajjeh RA

12

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Clinical Infectious Diseases

7 October 2017

1 reference

7 October 2017

29

1 reference

7 October 2017

5

1 reference

7 October 2017

1164-1170

1 reference

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species

7 October 2017

1 reference

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

21 January 2018

1 reference

Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B.

21 January 2018

1 reference

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States

21 January 2018

1 reference

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

21 January 2018

1 reference

Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group

21 January 2018

1 reference

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

21 January 2018

1 reference

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

21 January 2018

1 reference

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility

21 January 2018

1 reference

Fungal septicemia in patients receiving parenteral hyperalimentation

21 January 2018

1 reference

Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy

21 January 2018

1 reference

Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes

21 January 2018

1 reference

Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole

21 January 2018

1 reference

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/313450

1 reference

7 October 2017

1 reference